|
|
Volumn 20, Issue 2, 2008, Pages 155-161
|
|
The changing landscape of the medical management of skeletal metastases in nonsmall cell lung cancer
a
a
|
|
Author keywords
Bisphosphonates; Nonsmall cell lung cancer; Skeletal metastases; Zoledronic acid
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
AMINO TERMINAL TELOPEPTIDE;
AMINOBISPHOSPHONATE DERIVATIVE;
ANTINEOPLASTIC AGENT;
BISPHOSPHONIC ACID DERIVATIVE;
CORTICOSTEROID DERIVATIVE;
DENOSUMAB;
IBANDRONIC ACID;
PAMIDRONIC ACID;
PLACEBO;
SAMARIUM;
STRONTIUM;
UNCLASSIFIED DRUG;
ZOLEDRONIC ACID;
ANEMIA;
BONE METASTASIS;
BONE NECROSIS;
BONE PAIN;
BREAST CANCER;
CANCER RISK;
CANCER SURVIVAL;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONSTIPATION;
COST EFFECTIVENESS ANALYSIS;
DRUG BIOAVAILABILITY;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG INHIBITION;
DRUG WITHDRAWAL;
DYSPNEA;
HEALTH CARE COST;
HUMAN;
KIDNEY DYSFUNCTION;
LUNG NON SMALL CELL CANCER;
MONOTHERAPY;
MORBIDITY;
MULTIPLE MYELOMA;
NAUSEA;
NONHUMAN;
PATHOPHYSIOLOGY;
PREDICTION;
PRIORITY JOURNAL;
PROSTATE CANCER;
REVIEW;
SPINAL CORD COMPRESSION;
SURGICAL TECHNIQUE;
VOMITING;
BONE NEOPLASMS;
CARCINOMA, NON-SMALL-CELL LUNG;
HUMANS;
LUNG NEOPLASMS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 39849093875
PISSN: 10408746
EISSN: None
Source Type: Journal
DOI: 10.1097/CCO.0b013e3282f54cf2 Document Type: Review |
|
Times cited : (31)
|
|
References (44)
|
